Conclusion: Dose dense 4AC-4T regimen in neoadjuvant setting gives a high pCR rate with tolerable tocxicity, therefore this regimen can be widely used as neoadjuvant chemotherapy prior to surgery in our country, specilly with inoperable stage at initial diagnosis.